Recently, Fan et al developed a prognostic nomogram incorporated clinicopathologic factors (patient age, pT stage, pN stage, differentiation type, PNI, tumor deposits) with serum biomarkers (CEA and CA19-9 level) to predict survival outcome of rectal cancer patients (12). This evidence concerns the gene CEACAM5 and rectal cancer.